Crestwood Advisors Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.3M Sell
153,459
-10,141
-6% -$3.01M 0.76% 39
2025
Q4
$44.7M Sell
163,600
-7,280
-4% -$1.98M 0.74% 39
2025
Q3
$46.2M Sell
170,880
-421
-0.2% -$115K 0.78% 37
2025
Q2
$47.2M Buy
171,301
+49,070
+40% +$13.3M 0.85% 35
2025
Q1
$32.4M Buy
122,231
+7,139
+6% +$1.76M 0.62% 48
2024
Q4
$26.7M Buy
+115,092
New +$26.5M 0.5% 62
2018
Q1
Sell
-1,580
Closed -$231K 183
2017
Q4
$231K Buy
+1,580
New +$225K 0.02% 162

Other funds holding CME

Crestwood Advisors Group's CME Position: Q1 2026 in Review

Crestwood Advisors Group reduced its CME Group (CME) stake by 6.2% in Q1 2026, selling an estimated $3.01M and leaving 153,459 shares worth $45.3M. The position accounts for 0.76% of the portfolio, ranked #39.

Crestwood Advisors Group first reported a position in CME in Q4 2017 and has held it in 7 quarters since. The position peaked at $47.2M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Crestwood Advisors Group held 153,459 shares of CME Group worth $45.3M as of Q1 2026.
  • Crestwood Advisors Group sold 10,141 CME Group shares in Q1 2026, an estimated $3.01M.
  • CME Group made up 0.76% of Crestwood Advisors Group's portfolio in Q1 2026, its #39 holding.
  • Crestwood Advisors Group first reported a position in CME Group in Q4 2017 and has held it in 7 quarters since.
  • Crestwood Advisors Group's CME Group position peaked at $47.2M in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.